Sana Biotechnology shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Sana Biotechnology (SANA) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Sana Biotechnology
Tip: Access up to 7 years of quarterly data
All positions including Sana Biotechnology held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sana Biotechnology by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $499k | 141k | 3.55 |
| 2025-03-31 | $479k | 285k | 1.68 |
| 2024-12-31 | $455k | 279k | 1.63 |
| 2024-09-30 | $1.1M | 254k | 4.16 |
| 2024-06-30 | $1.3M | 247k | 5.46 |
| 2024-03-31 | $834k | 83k | 10.00 |
| 2023-12-31 | $266k | 65k | 4.08 |
| 2023-09-30 | $223k | 58k | 3.87 |
| 2023-06-30 | $124k | 38k | 3.27 |
| 2023-03-31 | $124k | 38k | 3.27 |
| 2022-12-31 | $208k | 53k | 3.95 |
| 2022-09-30 | $316k | 53k | 6.00 |
| 2022-06-30 | $467k | 73k | 6.43 |
| 2022-03-31 | $203k | 25k | 8.26 |
| 2021-12-31 | $381k | 25k | 15.48 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas